article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

Medicare negotiation authority; encourage biosimilars and generic drug utilization). The Plan also proposes establishing payment models to support the increased utilization of biosimilars and generics by further incentivizing providers to prescribe them. Increase Transparency and Strengthen Supply Chain and Research Capacity.